|
|
|
Company
Name |
Short
Summary |
| Altheus Therapeutics |
Altheus Therapeutics is focused on the develoment of therapies for the treatment of inflammatory bowel disease (IBD) with the initial focus on ulcerative colitis (UC). |
| Analytical Research Laboratories |
Analytical Research Laboratories (ARL) is focused on providing contract research laboratory services for the pharmaceutical industry. |
| Charlesson |
Charlesson is focused on the development of therapeutics for treating ophthalmic diseases. |
| CoMentis |
CoMentis is focused on the development of two technology platforms: (i) aspartic protease inhibitors and (ii) nicotinic acetylcholine receptor (nAChR) agonists and antagonists for the treatment of angiogenesis mediated or cognitive disorders. |
| Cytovance Biologics |
Cytovance Biologics is focused on providing biopharmaceutical contract manufacturing services to pharmaceutical and biotechnology copmanies. |
| Genzyme |
Genzyme
is a highly diversified family of companies committed
to redefining patient care worldwide through the
introduction of innovative products and services
for major unmet medical needs. |
| Otologic Pharmaceutics |
Otologic Pharmaceutics is focused on the discovery, research, and development of drugs and approaches that treat patients with hearing disorders. |
| Sensulin |
Sensulin is focused on the research and development of a once a day insulin using a drug delivery platform called Agglomerated Vesicle Technology (AVT). |
